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ABSTRAK
Nodul tiroid merupakan masalah kesehatan yang sering dijumpai dalam praktik sehari-hari, sehingga 
diperlukan panduan klinis. Pedoman ini dibuat oleh tim multidispilin, dan diharapkan dapat dijadikan panduan 
dalam melakukan pendekatan diagnosis nodul tiroid yang komprehensif dalam praktek klinis sehari-hari.
Kata kunci: nodul tiroid, pengelolaan nodul tiroid.
ABSTRACT
Thyroid nodule is a health problem which commonly found in daily practice, therefore clinical guidance is 
needed. This guideline was compiled by a multidisciplinary team and expected to be a guideline in diagnosing 
thyroid nodules on daily clinical practice.
Keywords: thyroid nodules, management of thyroid nodules.
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INTRODUCTION
Thyroid nodule are common health problems 
in clinical practice.1,2 Furthermore, with the 
advancement on the use of radiologic imaging, 
incidental findings of thyroid nodule are 
increasing. This will also urge the patients 
to seek medical advice to clinicians. Of all 
the 7.384 outpatient thyroid cases in RSUPN 
Dr.CiptoMangunkusumo, a tertiary care and a 
national referral hospital in Indonesia, dating 
from 2012 to 2016, about 68,7% of them 
were thyroid nodule cases. Among those 
thyroid nodule cases, 3-7% were incidental 
findings through physical examination or by the 
patient, while 67% were found on radiological 
examination (67% through USG examination, 
15% through cervical CT scan/ MRI, 1-2% 
through FDG-PET (fluorodeoxyglucose positron 
emission tomography).3 It is also important to 
note that even several studies have reported that 
around 20-76% population have at least one 
thyroid nodule.4
DIAGNOSIS
Evaluation in patients with thyroid nodules 
includes a detailed and relevant history, physical 
examination, laboratory test, radiologic imaging 
and, if needed, fine needle aspiration (FNA) 
biopsy
History
A detailed, structured, and relevant history 
taking needs to be conducted. This should 
include the searching for: pain at the front part 
of the neck, acute pain, severe pain, progressive 
enlargement (rapid growth is associated with 
high risk for malignancy, anaplastic carcinoma 
develops within 6 months, while papillar/ 
follicular carcinoma develops very slowly), 
dyspnea, suffocating sensation, cervical pain, 
dysphagia, hoarse voice, and symptoms of hyper- 
or hypo-thyroidism.1 It should also include 
disease history of thyroid disease, malignancy, 
whole body radiation, and childhood thyroid 
nodule. The presence of thyroid nodule in first 
degree family (parents, older siblings, younger 
siblings, or children) is a risk factor for thyroid 
nodule. Most of the nodules which do not show 
symptoms are benign. However, the lack of 
findings of malignancy symptoms does not rule 
out the chances of malignancy.5
Acute pain can be found on cystic nodule 
and thyroid infection. Severe pain and 
progressive growth may be a sign of anaplastic 
carcinoma or primary lymphoma. Suffocating 
sensation, cervical pain, dysphagia, and hoarse 
voice (dysphonia) may be caused by thyroid 
abnormalities, but are usually caused by diseases 
other than thyroid. Hoarse voice, vocal cord 
paralysis, tracheal compression symptoms 
(dysphoria, cough) may lead to suspicion of 
malignancy. The existence of fever, dysphagia, 
and malaise with thyroid pain may lead to a 
suspicion of subacute thyroiditis.1
Physical Examination
Physical examination through inspection and 
palpation need to be done thoroughly and should 
focus on thyroid gland and cervical lymphs. 
Take note on the volume, location, consistency, 
size, number, and tenderness of the nodule(s), 
as well as, if present, cervical adenopathy. Voice 
evaluation needs to be done for pre-operation 
purpose.1
Laboratory Examination
Laboratory examination is the initial step 
that needs to be done for all cases of thyroid 
nodule. Thyroid examination begins with 
examining Thyroid Stimulating Hormone (TSH) 
levels.1 (Figure 1) If the result is normal, no 
further examination of free thyroid hormone 
is needed. On the other hand, if TSH levels is 
abnormal, free thyroxin levels (FT4) should be 
tested. Low TSH and high FT4 confirms the 
presence of hyperthyroidism, while low TSH 
and normal FT4 might show the presence of 
subclinical hyperthyroidism or T3 toxicosis. 
Low TSH and low FT4 suggests the presence 
of central hypothyroidism. High TSH and high 
FT4 suggests central hyperthyroidism. While 
high TSH and low FT4 suggest the presence 
of primary hypothyroidism, high TSH and 
normal FT4 suggest the presence of subclinical 
hypothyroidism. If the TSH levels is high, the 
presence of thyroiditis should be considered and 
evaluated. Positive thyroid peroxidase antibody 
(TPO Ab) finding may lead to suspicion of thyroid 
autoimmune disease and Hashimoto’s Thyroiditis. 
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Radiology
Radiological examination of thyroid nodule 
is conducted to support the physical findings and 
laboratory results to ensure suitable and optimal 
classification of the thyroid nodule(s) and guide 
the treatment. High-resolution ultrasonography 
(USG) examination is considered the most sensitive 
method. Itenables clinicians to characterize 
palpable or non-palpable thyroid nodule and 
cervical lymphadenopathy, thus providing a valid 
malignancy risk stratification.1 USG examination 
is not recommended as a screening test for low-
risk patients with normally palpable thyroid. 
Newer USG technology has enabled clinicians 
to assess the vasculature of the thyroid, as well 
as performing elastography. Diagnosis of thyroid 
nodule(s) is established based on USG findings 
and, if necessary, the results from FNA (fine 
needle aspiration) biopsy (Table 1), which will 
be discussed in the next section.
The use of neck MRI and CT-scan may 
be considered to evaluate the size, respiratory 
passage compression, substernal extension, or 
pathological lymphatic nodes on cervical region 
that is not visible through USG examination.5 
Whereas in thyroid nodule(s) with intermediate 
cytology finding, the use of PET/ CT-scan may 
provide additional information on the risk of 
malignancy, the lack of diagnostic accuracy, 
high cost, and limited access precludes it’s use 
as a routine diagnostic procedure for thyroid 
nodule. PET and CT-scan may be considered for 
pre-operative malignant nodule with aggressive 
presentation.1
Thyroid scintigraphy is the only technique to 
evaluate functionality of thyroid nodule. Thyroid 
scintigraphy is indicated for low levels of TSH, 
ectopic thyroid suspicion, retrosternal struma 
(multinodalstruma that extend to intra-thoracal 
region), iodine deficiency. Thyroid scintigraphy 
can also be performed to evaluate the existence 
of hot nodule when TSH levels is low (0.5 – 1.0 
mIU/ L), and to evaluate feasibility for ablation 
therapy with radioactive iodine. Whole body scan 
with radioactive iodine (Nal-131) is performed 
to evaluate thyroid tissue residue and thyroid 
malignancy metastasis after total thyroidectomy.
FNA (Fine Needle Aspiration) Biopsy
The FNA biopsy should be done on thyroid 
lesion with the following findings on USG 
examination (Table 1): high risk of malignancy 
with size ≤10 mm,6-8 intermediate risk of 
malignancy with size >20 mm, and low risk of 
malignancy with size >20mm and progressively 
Figure 1. Laboratory examination algorithm in thyroid nodule diagnosis
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grows in size or has risk based on history and 
before thyroid operation or minimal invasive 
ablation therapy,9-11 nodule with USG finding 
that shows extra-capsular extension or cervical 
lymphatic nodes metastasis, nodules on patients 
with radiation history during childhood/ teenage 
years; family history11 with PTC, MTC, or MEN 2 
in the first degree family; thyroid surgery history; 
and increase levels of calcitonin with unrelated 
factors.
However, in several conditions FNA biopsy 
is not warranted. Low risk of malignancy 
with clinical presentation of nodule sizing <5 
mm is best observed than biopsy regardless 
of the thyroid USG finding, whilehigh risk of 
malignancy on USG findings with nodule sizing 
5-10 mm also does not call for FNA biopsy. 
Guided FNAB examination is considered more 
accurate for non-palpable thyroid nodule or 
lymph node, subcapsular or paratracheal lesion, 
suspicious lymph nodes, previous history or 
family history of thyroid cancer, and clinical 
findings such as dysphonia. FNA biopsy is less 
accurate on pediatric population, thus aggressive 
surgical excision is preferred. Several types 
of nodules, such as functional nodules on 





FNA size cutoff 
(largest dimension)
High suspicion
Solid hypoechoic nodule or solid hypoechoic component 
of a partially cystic nodule with one or more of the 
following features:
>70-90*
Recommend FNA at 
≥1 cm
irregular margins (infiltrative, microlobulated), 
microcalcifications, taller than wide shape, rim 
calcifications with small extrusive soft tissue component, 
evidence of ETE




Hypoechoic solid nodule with smooth margins without 
microcalcifications, ETE, or taller than wide shape
10-20
Recommend FNA at 
≥1.5 cm
Low suspicion
Isoechoic or hyperechoic solid nodule, or partially 
cystic nodule with eccentric solid areas, without 
microcalcification, irregular margin or ETE, or taller than 
wide shape.
5-10
Consider FNA at 
≥2 cm. Observation 
without FNA
Very low suspicion
Spongiform or partially cystic nodules without any of the 
sonographic features described in low, intermediate, or 
high suspicion patterns
<3
is also a reasonable 
option
Benign Purely cystic nodules (no solid component) <1 No biopsyb
a The estimate is derived from high volume centers, the overall risk of malignancy may be lower given the interobserver 
variability in sonography.
b Aspiration of the cyst may be considered for symptomatic or cosmetic drainage. ETE, extrathyroidal extension.
Adapted from 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and 
differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated 
thyroid cancer.
Table 2. Malignancy risk and clinical treatment based on Bethesda criteria.12
Diagnostic criteria Risk of malignancy (%) General treatment
Non-diagnostic or unsatisfactory (ND/UNS) 1-4 Repeat FNAB with ultrasonography
Benign 0-3 Clinical follow-up
Atypia of undetermined significance 
or follicular lesion of undetermined 
significance (AUS/FLUS)
~5-15 Repeat FNAB
Follicular neoplasm/ suspicious for a 
follicular neoplasm (FN/SFN)
15-30 Surgical lobectomy
Suspicious of malignancy (SUSP) 60-75 Near-total thyroidectomy or surgical lobectomy
Malignant 97-99 Near-total thyroidectomy
Adapted from The Bethesda system for reporting thyroid cytopathology, 2009
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scintigraphy, functional nodules on toxic Grave’s 
disease, and supposedly non-malignant nodules 
are not indicated for FNAB.
FNA biopsy result is reported based on 
the Bethesda System for Reporting Thyroid 
Cytopathology criteria.9 (Table 2) Malignancy 
risk of every category is then associated with 
rational clinical treatment guideline. The 
weakness of Bethesda criteria is its inability to 
show the exact number, only the depiction of 
quantity (many or few).
CONCLUSION
The optimal management of thyroid nodule 
calls for clinicians’ skilled handling on conducting 
the comprehensive diagnostic approach.
This comprehensive approach should include 
structured history taking, physical examination, 
laboratorium examination, radiology and, if 
needed, fine needle aspiration biopsy.
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